" class="no-js "lang="en-US"> Uncategorized Archives - Page 2 of 8 - Medtech Alert
Saturday, August 02, 2025

Sort by:

Date

Top Post

Almirall Appoints Mercedes Diz as VP, Corporate Strategy

Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]

CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development

CytoReason today announced an extension of its multi-year partnership with Pfizer to use CytoReason’s artificial intelligence […]

Calliditas’ Partner STADA Launches the First Medicine Authorized in the EU for Treating Primary IgA Nephropathy

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that its European commercial […]

Center for Breakthrough Medicines (CBM) and jCyte Announce Strategic Partnership to Manufacture jCyte's Innovative Cell Therapy for Treatment of Retinal Degenerative Diseases

The Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to addressing the […]

GenScript and Avectas Team Up to Improve the Non-Viral Cell Therapy Manufacturing Process

GenScript USA Inc., the world’s leading life-science research tools and services provider and Avectas, a cell engineering technology […]

Brain Navi Biotechnology Announced Partnership With Distributor, Medtreq Medical Equipment, to Enter the Middle East and Egypt With NaoTrac Neurosurgical Robot

Brain Navi, the leading surgical robot manufacture in Taiwan, announced a strategic partnership with distributor, Medtreq […]

Abbott Announces European Launch of Amplatzer™ Talisman™ System to Close Hole in Heart for People at Risk of Recurrent Stroke

Abbott today announced the European launch of its Amplatzer™ Talisman™ PFO Occlusion System to treat […]

First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN™ (valoctocogene roxaparvovec), Approved by European Commission (EC)

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that the European Commission (EC) has granted conditional marketing […]

Source BioScience Launches Sanger Sequencing Service in San Diego, CA to Support Life Science Researchers With Market-leading Genomic Services

A leading provider of Genomic services in the UK and Ireland, Source BioScience (“Source”), a part […]

DotLab Announces Three Granted Patents for Its Non-invasive Test for Endometriosis, DotEndo™

DotLab, a medical diagnostics company, announced that the United States Patent and Trademark Office has […]

Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery

Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, today announced […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more